MANGABEY is a Paris-based data-focused consulting firm in the pharmaceutical industry that is making waves with its unique approach to data unification. The company, established in 2022, works with experts from diverse backgrounds and know-how, providing a unique service to the pharmaceutical industry. These include building global data capabilities for pharma companies, healthcare innovation, and pharmaceutical business analytics.
Led by CEO Moktar DIALLO, the company's agile and teamwork-oriented approach involves collaborating with the company's various subsidiaries and bodies to achieve data unification, which is crucial for their continued success.
In today's digital age, the pharmaceutical industry, like many others, is undergoing digitization. For instance, the top 20 pharma companies collectively spend an astounding $5 billion annually on data acquisition. However, companies are facing internal challenges to progress and deliver durable transformations. They are also struggling to implement the necessary strategies to better manage and integrate data. This is where MANGABEY comes in, offering data unification services to pharmaceutical firms.
While most companies make large investments in sophisticated technology, many of them don’t know how to use the technology to leverage their data. Since any technology is only as reliable as the data fed to it, companies must prioritize data management if they want to get the most out of their investments.
MANGABEY believes that by unifying your data you can unify your business. Sometimes, people focus too much on the technological aspects and forget to perfect the data input. Having a unified system brings together different teams and departments in a streamlined and adaptable manner. It eliminates silos, ensuring that communications are in line with and maintaining overall business unity. It also leads to the alignment of internal teams towards the longer-term goal of digitization and functionality expansion, which accelerates business sharing and innovation. Unlike a single large update that destroys other processes, a unified business operating system is gradually improved over time, preventing fragmentation of other operations.
Founded by former pharmaceutical executives, MANGABEY has insider knowledge of the industry's challenges and opportunities. It uses this expertise to work closely with clients and understand their unique needs and challenges, providing customized, data-driven solutions that deliver tangible results and transform business practices. MANGABEY understands that data is more than just a commodity – it is a catalyst for change. It unlocks the full potential of data, by breaking down barriers that hinder effective utilization, promoting collaboration within organizations and across the industry.
Data stagnation results in large amounts of unused data that are not being utilized by businesses. To overcome this, MANGABEY helps clients consolidate and structure data while implementing proper governance measures. This effort requires not just technical skills but also communication and change management expertise.
MANGABEY utilizes the "4 levers" framework to assess clients’ current data situations and then develop unique and customized data solutions. These levers are data governance, data purchase, data harmonization, and digital integration. By following this framework, it enables its clients to access and analyze their data in real time without the hassle of dealing with duplicate datasets. MANGABEY’s focus on data unification means that its clients can be confident that the data they are using is clear, reliable, consistent, and up to date.
The company’s innovative approach to data unification is already making a significant impact in the pharmaceutical industry. At least 150,000 hours of data acquisition work each year is still done manually today, and MANGABEY can aid the industry by cutting this figure by over 90%, saving over $1 billion per year for the top 20 pharmaceutical companies. This allows companies to redirect their funding towards innovation.
MANGABEY recognizes the vastness of the industry across verticals and the need for data expertise in numerous startups. Therefore, it is constantly on the lookout for new companies to partner with, in order to expand their reach across the globe. As a result, the company’s growth prospects appear promising as it continues to address the issue of data stagnation in the pharmaceutical industry.
About MANGABEY
MANGABEY is a data-focused consulting firm that is revolutionizing the pharmaceutical industry with its innovative approach to data unification. The company is headquartered in Paris, France, and was founded in 2022. With the use of technology and a unique teamwork-oriented approach, the company is helping pharmaceutical firms optimize their operations and respond to the health needs of patients while driving innovation.
Media contact:
Name: Maria Cano
Email: [email protected]
